(Q68101494)
Statements
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (English)
K. Mattson
A. Kirkpatrick
D. Evrard
L. Tammilehto
F. J. van Breukelen
H. T. Planteydt